ZBIO
Zenas BioPharma, Inc. Common Stock
NASDAQ: ZBIO · HEALTHCARE · BIOTECHNOLOGY
$17.55
-2.55% today
Updated 2026-04-29
Market cap
$1.09B
P/E ratio
—
P/S ratio
109.46x
EPS (TTM)
$-8.44
Dividend yield
—
52W range
$9 – $45
Volume
0.7M
Zenas BioPharma, Inc. Common Stock (ZBIO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-65.65M | $-30.53M | $-119.67M | $-172.33M |
| Capital expenditures | $2.20M | $17000.00 | $131000.00 | $18000.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $737000.00 | $3.50M | $10.82M | $26.35M |
| Free cash flow | $-67.85M | $-30.55M | $-119.81M | $-172.35M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |